Vietnam’s MedTech sector is developing quickly, driven by rising healthcare demand and accelerating digital adoption. However, Vietnam does not yet have a single, unified regulatory framework for MedTech; instead, activities in this space fall under a mix of laws governing healthcare, pharmaceuticals, e‑commerce, and information technology. In this context, understanding how different MedTech models are regulated is essential for investors and businesses entering the market.
Vietnam’s MedTech opportunity in 2026 is accelerating rapidly, led by strong growth in digital health and telemedicine. The telemedicine market reached USD 0.40 billion in 2025 and is projected to grow at a 12.4% CAGR from 2026 to 2034, driven by rising demand for remote healthcare services. Broader digital health is also expanding, valued at USD 926 million in 2024 and supported by Vietnam’s National Digital Transformation Program, which dedicates VND 30 trillion (USD 1.26 billion) to modernising healthcare infrastructure and digital solutions nationwide.
Key MedTech segments in Vietnam
In Vietnam, MedTech generally refers to the use of modern technologies in healthcare to improve efficiency, transparency, and access to medical services, often at a lower cost than traditional healthcare models. According to the Ministry of Science and Technology, MedTech solutions support both patients and healthcare providers through digital tools without needing to go to medical agencies.
The main MedTech segments include:
a) Telemedicine and teleconsultation
Telemedicine uses digital technologies to deliver healthcare remotely, allowing doctors to diagnose, treat, monitor patients, and give medical advice through calls, video consultations, mobile apps, or other online platforms. In practice, some providers also prescribe and sell medicines (such as YouMed). This model expands access to healthcare, especially for people who have difficulty visiting medical facilities.
b) Healthcare information systems and software
Common solutions include:
- Electronic Health Records (EHRs): Digital patient records that store medical history, diagnoses, medications, test results, and treatment plans.
- Practice Management Software: Systems that support appointment scheduling, billing, and reporting.
- Clinical Decision Support Systems (CDSS): Tools that assist healthcare professionals by providing relevant clinical information at appropriate times.
c) Telemedicine platforms
Telemedicine platforms function as e-commerce platforms for healthcare services. They connect patients with licensed medical providers, allowing consultations to take place remotely. In most cases, the platform operator does not provide medical services directly but acts as a technology intermediary.
d) High-Tech medical equipment manufacturing
Medical devices such as X-ray machines and CT scanners are classified as high-technology products. Many manufacturers use advanced technologies such as artificial intelligence and robotics in the production process.
Overview of the legal framework
While MedTech activities operate across several different business models, each category is subject to its own regulatory requirements under the relevant sectoral laws. These requirements vary depending on whether a business provides medical services, develops software, operates an online platform, or manufactures medical equipment.
a) Market entry for foreign investors
Both local and foreign investors may only operate within their registered business lines. Foreign investors face additional market access restrictions, particularly in sensitive sectors such as healthcare. Vietnamese authorities assess foreign investment applications based on:
Level 1: Free trade agreements and international treaties to which Vietnam and the investor’s home country are parties
Level 2: Vietnamese laws
| Segment | Objective Operation | Business Lines | Market Entry Conditions |
|---|---|---|---|
| Telemedicine and Teleconsulting | Hospital, dental and medical services (CPC 9312) | General, specialised and dental clinic operations (VSIC 8620) Other medical activities not yet classified (VSIC 8699) | For WTO member countries: • Foreign investors may provide services through:
Minimum investment capital:
For AFAS, EVFTA, and UKFTA members:
|
| Retail Sale of Pharmaceuticals | Pharmaceutical retail (VSIC 4772) | Vietnam has not committed to opening pharmaceutical distribution to foreign investors under international treaties. Foreign-owned companies may import pharmaceuticals but may not distribute (retail or wholesale) them, except for drugs and medicinal ingredients manufactured by their own facilities in Vietnam (Decree 54/2017/ND-CP). | |
| Healthcare Information Systems and Software | Computer services and related services (CPC 841–845, 849) | Computer programming (VSIC 6201) Computer consultancy and system management (VSIC 6202) Other IT-related services (VSIC 6209) | Under Vietnam’s WTO commitments, foreign investors from WTO member states may establish 100% foreign-owned enterprises to provide IT-related services, including software development, data processing and system implementation. |
| Telemedicine Platform | E-commerce platform for medical services | Web portal (VSIC 6312) | Vietnam has not yet committed to opening this sector to foreign investors under international treaties. According to Decree 52/2013/ND-CP, amended by Decree 85/2021/ND-CP: 1. Foreign investors may invest by:
2. National security review required if a foreign investor controls one or more of the top five e-commerce platforms in Vietnam (based on traffic, sellers, transactions, or transaction value). In particular, a foreign investor is considered to have control if it: a. Holds more than 50% of charter capital or voting shares b. Has the right to appoint or dismiss key management Investors have the right to decide important business issues (technology platform, business model, industry, profession, location, scale, business lines, capital use). |
| Manufacturing Medical Equipment | Manufacturing-related services (CPC 884, 885) | Manufacture of medical, dental, orthopedic and rehabilitation equipment (VSIC 3250) | 100% foreign-owned companies are permitted. |
b) Operational requirements for Medtech activities
Healthcare Information Systems and software are non-conditional IT business lines and do not require specific operating licenses. However, foreign-invested enterprises operating in telemedicine services, telemedicine platforms, or medical equipment manufacturing must comply with additional regulatory requirements, as outlined below.
Telemedicine services
Article 87 Decree 96/2023/ND-CP requires any telemedicine provider to satisfy the following requisites:
- The provider must be established as a licensed medical facility under Article 39 of Decree 96/2023/ND-CP, such as a hospital, clinic, medical station, traditional medicine facility, or family medical practice.
- They must obtain the Operating License and provide service within the scope of service under this license
- Telemedicine services may only be provided for diseases and medical conditions approved for remote treatment under Circular 30/2023/TT-BYT, such as:
| Specialist | Disease, medical condition |
|---|---|
| Nutrition | Obesity |
| Ear, nose and throat | Acute nasopharyngitis |
| Heart | Hypertension |
- Services must be performed by a practitioner qualified by License to practice medicine.
- Providers must have adequate IT systems, medical equipment, and software to ensure secure transmission, processing, storage, and backup of medical data in compliance with legal requirements.
- Announcing eligibility to conduct telemedicine.
If a telemedicine provider develops and operates its own website or mobile application, it must also register or notify the platform with the Ministry of Industry and Trade (MOIT). This notification allows authorities to monitor the services provided and any subsequent changes.
Telemedicine platforms
For this model, the platform operator owns and operates an e-commerce platform that connects licensed medical service providers with patients. Medical service providers are responsible for service quality and for obtaining all required licenses.
As the platform operator does not directly provide medical services or medical goods, it is not subject to medical licensing requirements. The operator registers IT-related business lines, which are generally open to foreign investors in Vietnam. However, as e-commerce is a conditional business line, the operator must obtain an e-commerce trading license under Decree No. 09/2018/ND-CP and register its website with the Ministry of Industry and Trade (MOIT) in accordance with Decree No. 52/2013/ND-CP, as amended by Decree No. 85/2021/ND-CP. Upon registration, the platform is issued an MOIT certification badge, which must be displayed on the website.

Notable regulations on personal data processing
Vietnam has strengthened its personal data protection framework in recent years. The Government first introduced Decree 13/2023/ND‑CP as the country’s initial regulation on personal data protection. This has since been replaced by the new Personal Data Protection Law (PDP Law), effective from 1 January 2026, which serves as Vietnam’s first comprehensive data privacy legislation. The PDP Law is further guided by Decree 356/2025/ND‑CP, setting out stricter rules on consent, data security, cross‑border data transfers, and compliance obligations for businesses processing personal data in Vietnam.
Under the prevailing regulations, personal data processing covers activities such as collection, recording, storage, analysis, sharing, transfer, and deletion of personal data. In the operation of a telemedicine platform, personal data of patients and medical service providers is collected and processed. Accordingly, telemedicine platform operators are regarded as personal data processors and are subject to the PDP Law.
Key obligations include:
- Consent: Obtaining valid and informed consent from data subjects
- Purpose limitation: Processing data only for stated and lawful purposes
- Data minimisation: Collecting and retaining data only to the extent necessary
- Data security: Implementing appropriate technical and organisational safeguards.
Telemedicine platforms must therefore ensure compliance with data protection requirements to protect patient information and avoid regulatory risks.
Please visit here for details and guidance to comply with Decree 13.
Manufacturing of medical equipment
Decree 98/2021/ND-CP governs the manufacture and import of medical equipment in Vietnam. All medical devices must be registered with the Ministry of Health and classified based on risk level:
| Classification | Level of risk | Compliance procedure |
|---|---|---|
| A | Low | Declaration of applicable standards |
| B | Low to moderate | Declaration of applicable standards |
| C | Moderate to high | Circulation registration |
| D | High | Circulation registration |
Manufacturers must also:
- Comply with ISO 13485 standards
- Declare eligibility for medical device manufacturing in accordance with Articles 8 and 9 of Decree 98/2021/ND-CP.
Manufacturers applying high technology in production may qualify for tax incentives, including:
- Corporate income tax (CIT) rate of 10% for 15 years
- CIT exemption for the first 4 years
- 50% CIT reduction for the next 9 years.
To access these incentives, manufacturers must be officially recognised as high-tech enterprises or certified as applying high technology under applicable regulations.
Navigating challenges and capturing opportunities
Vietnam’s MedTech sector is advancing quickly, and businesses often find that the real challenge lies in interpreting how regulatory requirements apply to their specific model. Questions around licensing, data obligations and operational scope often become pivotal as companies move from concept to deployment.
This can slow early progress; however, it also rewards investors who take time to establish the right structure from the outset. Companies that understand the regulatory expectations for their model tend to build stronger foundations and collaborate more effectively with hospitals, regulators and local partners.
As Vietnam accelerates its digital health agenda, opportunities in Vietnam’s MedTech market are becoming more pronounced. Demand for accessible, technology enabled healthcare continues to grow, and policy signals point toward ‑enabled healthcare continues to grow, and policy signals point toward long‑term support for innovation.
Acclime works closely with investors and MedTech operators at each stage of their journey. We assist with selecting the right market entry route, securing licences, and ensuring platform and data compliance, providing the clarity and confidence companies need to navigate Vietnam’s evolving environment and position themselves for sustainable growth.
Reach out to our experts:
Rizwan Khan – Managing Partner – [email protected]
Nguyen Phuong Thao – Senior Manager – Licensing and Corporate Secretarial – [email protected]
Nguyen Cong Huy – Supervisor – Licensing and Corporate Secretarial – [email protected]



